Croda International plc announce an interim dividend in respect of 2025 of 48.0p per share, amounting to a total dividend of £67.0m, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025.
Other financial highlights include:
o Consumer Care sales +7%, benefitting from higher sales volumes
Beauty Actives +1%, Beauty Care +3%, Fragrances & Flavours (F&F) +17%, Home Care +7%
o Life Sciences sales +9%, growing in all regions
Seed +17% and Crop +12% with improved demand from multi-national customers (MNCs)
Pharma +5% with continued biopharma growth and slow recovery in consumer health
o Industrial Specialties sales +4%
o Q2 sales remained 6% ahead of prior year at constant currency but were sequentially lower than Q1
Adjusted operating profit +12% at constant currency
o Adjusted operating margin 17.2% (H124: 16.6%)
Supported by higher volumes and cost savings initiatives; partly offset by FX and price/mix
o IFRS profit before tax of £85.5m (H124: £106.1m); adjustments included £27.3m impairment charges
o Adjusted profit before tax up 8% to £138.0m (H124: £127.3m); equivalent to £142.5m at constant currency
Resilient balance sheet
o Cashflow reflected lower capex and higher working capital with inventory and debtors adverse
o Leverage ratio 1.5x (H124: 1.4x), well within their target range of 1-2x EBITDA
o Dividend increased 1p to 48.0p (H124: 47.0p), maintaining record of progression
